A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma

被引:399
作者
Sorbellini, M
Kattan, MW
Snyder, ME
Reuter, V
Motzer, R
Goetzl, M
McKiernan, J
Russo, P
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[4] Columbia Univ, Dept Urol, New York, NY USA
关键词
carcinoma; renal cell; prognosis; proportional hazards models;
D O I
10.1097/01.ju.0000148261.19532.2c
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Few published studies have simultaneously analyzed multiple prognostic factors to predict recurrence after surgery for conventional clear cell renal cortical carcinomas. We developed and performed external validation of a postoperative nomogram for this purpose. We used a prospectively updated database of more than 1,400 patients treated at a single institution. Materials and Methods: From January 1989 to August 2002, 833 nephrectomies (partial and radical) for renal cell carcinoma of conventional clear cell histology performed at Memorial Sloan-Kettering Cancer Center were reviewed from the center's kidney database. Patients with von Hippel-Lindau disease or familial syndromes, as well as patients presenting with synchronous bilateral renal masses, or distant metastases or metastatic regional lymph nodes before or at surgery were excluded from study. We modeled clinicopathological. data and disease followup for 701 patients with conventional clear cell renal cell carcinoma. Prognostic variables for the nomogram included pathological stage, Fuhrman grade, tumor size, necrosis, vascular invasion and clinical presentation (ie incidental asymptomatic, locally symptomatic or systemically symptomatic). Results: Disease recurrence was noted in 72 of 701 patients. Those patients without evidence of disease had a median and maximum followup, of 32 and 120 months, respectively. The 5-year probability of freedom from recurrence for the patient cohort was 80.9% (95% confidence interval 75.7% to 85.1%). A nomogram was designed based on a Cox proportional hazards regression model. Following external validation predictions by the nomogram appeared accurate and discriminating, and the concordance index was 0.82. Conclusions: A nomogram has been developed that can be used to predict the 5-year probability of freedom from recurrence for patients with conventional clear cell renal cell carcinoma. This nomogram may be useful for patient counseling, clinical trial design and effective patient followup strategies.
引用
收藏
页码:48 / 51
页数:4
相关论文
共 20 条
[1]   Stage pT1 conventional (clear cell) renal cell carcinoma: Pathological features associated with cancer specific survival [J].
Cheville, JC ;
Blute, ML ;
Zincke, H ;
Lohse, CM ;
Weaver, AL .
JOURNAL OF UROLOGY, 2001, 166 (02) :453-456
[2]   Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma - Assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters [J].
Delahunt, B ;
Kittelson, JM ;
McCredie, MRE ;
Reeve, AE ;
Stewart, JH ;
Bilous, AM .
CANCER, 2002, 94 (03) :658-664
[3]  
Eastham James A, 2002, Semin Urol Oncol, V20, P108, DOI 10.1053/suro.2002.32936
[4]   PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[5]  
Greene FL., 2002, AJCC CANC STAGING HD, V6th
[6]   Cancer statistics, 2004 [J].
Jemal, A ;
Tiwari, RC ;
Murray, T ;
Ghafoor, A ;
Samuels, A ;
Ward, E ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2004, 54 (01) :8-29
[7]  
Kattan Michael W, 2002, Semin Urol Oncol, V20, P79
[8]   A postoperative prognostic nomogram for renal cell carcinoma [J].
Kattan, MW ;
Reuter, V ;
Motzer, RJ ;
Katz, J ;
Russo, P .
JOURNAL OF UROLOGY, 2001, 166 (01) :63-67
[9]   Quantitative assessment of vascular surface density in renal cell carcinomas [J].
Kohler, HH ;
Barth, PJ ;
Siebel, A ;
Gerharz, EW ;
Bittinger, A .
BRITISH JOURNAL OF UROLOGY, 1996, 77 (05) :650-654
[10]  
Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO